Detalhe da pesquisa
1.
Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease.
Int J Med Sci
; 16(7): 909-921, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31341404
2.
Association of mRNA expression of iron metabolism-associated genes and progression of non-alcoholic steatohepatitis in rats.
Oncotarget
; 9(40): 26183-26194, 2018 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29899851
3.
Apoptosis and non-alcoholic fatty liver diseases.
World J Gastroenterol
; 24(25): 2661-2672, 2018 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29991872
4.
Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b.
World J Gastroenterol
; 23(46): 8120-8127, 2017 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29290649
5.
Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors.
World J Gastroenterol
; 19(30): 4887-96, 2013 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23946593
6.
Zinc supplementation therapy improves the outcome of patients with chronic hepatitis C.
J Clin Biochem Nutr
; 51(3): 178-84, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23170044
7.
Treatment effects and predictors of a 24-week course of interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C.
J Gastroenterol Hepatol
; 21(7): 1177-83, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16824072